SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-21-029354
Filing Date
2021-05-26
Accepted
2021-05-26 16:22:47
Documents
2
Period of Report
2021-05-26

Document Format Files

Seq Description Document Type Size
1 FORM 6-K ea141768-6k_chinasxt.htm 6-K 20157
2 DIRECTOR OFFER LETTER OF XIAODONG JI, DATED MAY 22, 2021 ea141768-ex4_1chinasxt.htm EX-4.1 24404
  Complete submission text file 0001213900-21-029354.txt   45546
Mailing Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300
Business Address 178 TAIDONG ROAD NORTH TAIZHOU F4 225300 8652386298290
China SXT Pharmaceuticals, Inc. (Filer) CIK: 0001723980 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: 6-K | Act: 34 | File No.: 001-38773 | Film No.: 21966305
SIC: 2834 Pharmaceutical Preparations